Edition:
United States

CymaBay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Capital Market

8.58USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$8.58
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
263,361
52-wk High
$9.40
52-wk Low
$1.46

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.206
Jun '17 0.00 -0.311
Mar '17 4.79 -0.201
FY 2016 Dec '16 0.00 -0.296
Sep '16 0.00 -0.251
Jun '16 0.00 -0.298
Mar '16 0.00 -0.292
FY 2015 Dec '15 0.00 -0.254
Sep '15 0.00 -0.271
Jun '15 0.00 -0.089
Mar '15 0.00 -0.154
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 2.00 10.00 0.00 0.00
Quarter Ending Mar-18 4 0.00 0.00 0.00 --
Year Ending Dec-17 5 6.80 14.79 4.79 0.00
Year Ending Dec-18 6 9.33 36.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 5 -0.14 0.03 -0.22 -0.28
Quarter Ending Mar-18 4 -0.22 -0.17 -0.28 --
Year Ending Dec-17 5 -0.83 -0.62 -0.93 -1.11
Year Ending Dec-18 5 -0.91 -0.82 -1.02 -1.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.97 34.69
P/E High - Last 5 Yrs. -- 286.63 45.18
P/E Low - Last 5 Yrs. -- 95.71 24.22
Beta 2.12 0.85 0.89
Price to Sales (TTM) 78.52 95.73 5.34
Price to Book (MRQ) 4.35 20.97 5.60
Price to Tangible Book (MRQ) 4.35 24.54 7.13
Price to Cash Flow (TTM) -- 100.37 23.62
% Owned Institutions 69.57 6.16 1.29

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.03
Dividend 5 Year Growth Rate -- 2.03 5.31
Payout Ratio(TTM) -- 105.08 45.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.02 6.92
Sales (TTM) vs TTM 1 Yr. Ago -- 28.29 5.15
Sales - 5 Yr. Growth Rate -- 33.47 10.37
EPS (MRQ) vs Qtr. 1 Yr. Ago 17.97 -143.59 4.97
EPS (TTM) vs TTM 1 Yr. Ago 7.45 -- --
EPS - 5 Yr. Growth Rate -- 43.52 10.99
Capital Spending - 5 Yr. Growth Rate 2.57 41.25 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.89 2.54
Current Ratio (MRQ) 7.39 5.55 3.56
LT Debt to Equity (MRQ) 4.40 14.62 12.32
Total Debt to Equity (MRQ) 7.87 16.95 18.28
Interest Coverage (TTM) -21.88 -149.32 43.76

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.41 54.71
Gross Margin - 5 Yr. Avg. -- 55.10 52.20
EBITD Margin (TTM) -492.84 -- --
EBITD - 5 Yr. Avg -3,117.44 -212.32 15.66
Operating Margin (TTM) -493.55 -529.22 8.10
Operating Margin - 5 Yr. Avg. -3,125.41 -227.74 11.31
Pre-Tax Margin (TTM) -614.77 -498.18 8.94
Pre-Tax Margin - 5 Yr. Avg. -3,129.34 -227.60 11.72
Net Profit Margin (TTM) -614.77 -495.43 5.17
Net Profit Margin - 5 Yr. Avg. -3,129.34 -230.67 8.00
Effective Tax Rate (TTM) -- 15.49 24.18
Effective Tax Rate - 5 Yr. Avg. -- 19.01 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,262,136 865,539,949
Net Income/Employee (TTM) -- -1,547,056 100,926,146
Receivable Turnover (TTM) -- 27.57 6.13
Inventory Turnover (TTM) -- 2.68 3.53
Asset Turnover (TTM) 0.07 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.64 -8.33 11.39
Return on Assets - 5 Yr. Avg. -67.82 -0.09 12.42
Return on Investment (TTM) -54.90 -10.87 14.55
Return on Investment - 5 Yr. Avg. -118.36 3.10 16.27
Return on Equity (TTM) -60.93 -36.85 16.05
Return on Equity - 5 Yr. Avg. -- 5.64 17.42
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -38.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for CymaBay Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.33%
# of Holders: 79
Total Shares Held: 32,606,258
3 Mo. Net Change: 20,584,185
# New Positions: 41
# Closed Positions: 10
# Increased Positions: 68
# Reduced Positions: 17
# Net Buyers: 51
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.